Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

Alessandro Busca, Franco Locatelli, Filippo Marmont, Cristina Ceretto, Michele Falda

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences